Newton M W, Ringdahl B, Jenden D J
J Pharmacol Exp Ther. 1985 Oct;235(1):147-56.
The metabolism of the choline analog N-amino-N,N-dimethylaminoethanol (N-aminodeanol) by isolated rat diaphragm and guinea-pig myenteric plexus preparations and the pharmacological properties of the acetate ester were studied. Deuterium-labeled N-aminodeanol was transported and acetylated by rat diaphragm and guinea-pig myenteric plexus preparations. Diaphragms stimulated indirectly in the presence of [2H4]N-aminodeanol (2 X 10(-5) M) released [2H4]acetyl-N-aminodeanol at 38% the rate at which [2H4]acetylcholine was released from controls incubated with [2H4]choline (2 X 10(-5) M). In the guinea-pig myenteric plexus, [2H4]acetyl-N-aminodeanol was synthesized and released at a rate up to 70% that measured for [2H4] acetylcholine. N-methylatropine (10(-7) M) enhanced the stimulated release of [2H4]acetyl-N-aminodeanol and [2H4] acetylcholine (in separate controls) by the same amount (2,3-fold). After incubation in the presence of [2H4]N-aminodeanol, [2H4]acetyl-N-aminodeanol replaced (mole for mole) 17 and 50% of the endogenous acetylcholine tissue content in diaphragm and myenteric plexus, respectively. As the tissue [2H0]acetylcholine was replaced, its release was reduced to 38 and 22% of control in diaphragm and myenteric plexus, respectively. Combined transmitter release (true + false) was reduced to 56 to 79% of release from controls. Endogenous choline efflux apparently limited the replacement of true with false transmitter in these preparations. Acetyl-N-aminodeanol had 4 and 17% the potency of acetylcholine on the guinea-pig ileum and frog rectus abdominis preparations, respectively. These findings indicate that [2H4]N-aminodeanol forms a false transmitter in rat diaphragm and guinea-pig myenteric plexus and may potentially interfere with cholinergic function. Effective replacement of endogenous acetylcholine in vivo would also require replacement of endogenous sources of choline for transmitter synthesis.
研究了胆碱类似物N-氨基-N,N-二甲基氨基乙醇(N-氨基乙醇)在离体大鼠膈肌和豚鼠肠肌丛制剂中的代谢以及乙酸酯的药理特性。氘标记的N-氨基乙醇被大鼠膈肌和豚鼠肠肌丛制剂转运并乙酰化。在[2H4]N-氨基乙醇(2×10(-5)M)存在下间接刺激的膈肌释放[2H4]乙酰-N-氨基乙醇的速率是与[2H4]胆碱(2×10(-5)M)孵育的对照释放[2H4]乙酰胆碱速率的38%。在豚鼠肠肌丛中,[2H4]乙酰-N-氨基乙醇的合成和释放速率高达[2H4]乙酰胆碱测定速率的70%。N-甲基阿托品(10(-7)M)使[2H4]乙酰-N-氨基乙醇和[2H4]乙酰胆碱(在单独的对照中)的刺激释放增加相同的量(2至3倍)。在[2H4]N-氨基乙醇存在下孵育后,[2H4]乙酰-N-氨基乙醇分别取代了膈肌和肠肌丛中内源性乙酰胆碱组织含量的17%和50%(摩尔比)。随着组织中[2H0]乙酰胆碱被取代,其释放在膈肌和肠肌丛中分别降至对照的38%和22%。联合递质释放(真+假)降至对照释放的56%至79%。内源性胆碱流出显然限制了这些制剂中真递质被假递质的取代。乙酰-N-氨基乙醇对豚鼠回肠和青蛙腹直肌制剂的效力分别为乙酰胆碱的4%和17%。这些发现表明,[2H4]N-氨基乙醇在大鼠膈肌和豚鼠肠肌丛中形成假递质,并可能潜在地干扰胆碱能功能。在体内有效取代内源性乙酰胆碱还需要取代用于递质合成的内源性胆碱来源。